close

"We are still at an early stage of the viral hepatitis response, but the way forward looks promising," said Gottfried Hirnschall, Director of WHO's Department of HIV and the Global Hepatitis Programme, adding that "more countries are making hepatitis services available for people in need, a diagnostic test costs less than 1 dollar and the cure for HCV can be below 200 dollars ."

The report also revealed that increased coverage of HBV vaccinations among children have contributed substantially to preventing deaths from that virus.


Vast majority of people living with hepatitis have no access to testing or treatment, WHO says

UNITED NATIONS, April 21 (Xinhua) -- A vast majority of the estimated 325 million people living with chronic hepatitis B virus or hepati瑩潤隔離霜｜瑩潤隔離霜推薦tis C virus infection lack access to life-saving testing and treatment, according to the new data published Friday by the UN World Health Organization (WHO).

HBV infection requires lifelong treatment, and Hepatitis C can be cured within a relatively short time using the correct medicines, making the need for testing and treatment all the more important.

According to WHO's 2017 Global Hepatitis Report, just 9 percent of all hepatitis潔面凝膠推薦｜淨化潔面凝膠成分 B virus (HBV) and hepatitis C virus (HCV) infections were diagnosed in 2015. An even smaller fraction, merely 8 percent and 7 percent, of those diagnosed with HBV and HCV, respectively, started curative treatment during that year.

"Viral hepatitis is now recognized as a major public health challe氨基酸深層潔顏霜｜氨基酸深層潔顏霜推薦nge that requires an urgent response," said Margaret Chan, the Director-General of WHO, in a news release announcing the findings.

A woman receives a vaccine for Hepatitis B at a stand during a fair for basic services in prevention of disease in the context of the World Health Day's commemoration, in Buenos Aires, Argentina, on April 7, 2015. (Xinhua/Martin Zabala)

"We are still at an early stage of the viral hepatitis response, but the way forward looks promising," said Gottfried Hirnschall, Director of WHO's Department of HIV and the Global Hepatitis Programme, adding that "more countries are making hepatitis services available for people in need, a diagn專櫃隔離霜推薦｜專櫃隔離霜推薦2017ostic test costs less than 1 dollar and the cure for HCV can be below 200 dollars ."

"Viral hepatitis is now recognized as a major public health challenge that requires an urgent response," said Margaret Chan, the Director-General of WHO, in a news release announcing the findings.

According to WHO's 2017 Global Hepatitis Report, just 9 percent of all hepatitis B virus (HBV) and hepatitis C virus (HCV) infections were diagnosed in 2015. An even smaller fraction, merely 8 percent and 7 percent, of those diagnosed with HBV and HCV, respectively, started curative treatment during that year.

Vast majority of people living with hepatitis have no access to testing or treatment, WHO says




A woman receives a vaccine for Hepatitis B at a stand during a fair for basic services in prevention of disease in the context of the World Health Day's commemoration, in Buenos Aires, Argentina, on April 7, 2015. (Xinhua/Martin Zabala)

UNITED NATIONS, April 21 (Xinhua) -- A vast majority of the estimated 325 million people living with chronic hepatitis B virus or hepatitis C virus infection lack access to life-saving testing and treatment, according to the new data published Friday by the UN World Health Organization (WHO).

UN health agency said hepatitis virus infection placed them at a great risk of chronic liver disease, cancer, and even death.

UN health agency said hepatitis virus infection placed them at a great risk of chronic liver disease, cancer, and even death.

However, an estimated 257 million people, mostly adults born before the introduction of the HBV vaccine, were living with chronic HBV infection in 2015. There is also currently no vaccine against HCV, and access to treatment for both HBV and HCV is low.

The report also revealed that increased coverage of HBV vaccinations among children have contributed substantially to preventing deaths from that virus.

Globally, 84 percent of children born in 2015 received 深層潔顏膠｜深層潔顏膠推薦the three recommended doses of HBV vaccine.

However, an estimated 257 million people, mostly adults born before the introduction of the HBV vaccine, were living with chronic HBV infection in 2015. There is also currently no vaccine against HCV, and access to treatment for both HBV and HCV is low.

HBV infection requires lifelong treatment, and Hepatitis C can be cured within a relatively short time using the correct medicines, making the need for testing and treatment all the more important.

Globally, 84 percent of children born in 2015 received the three recommended doses of HBV vaccine.
arrow
arrow
    文章標籤
    光采精華露｜光采精華露推薦 D.B龍寶貝 麒麟生技｜鱘龍魚保養品｜DB龍寶貝精華 氨基酸深層潔顏霜｜氨基酸深層潔顏霜推薦 深層潔顏膠｜深層潔顏膠推薦 專櫃隔離霜推薦｜專櫃隔離霜推薦2017
    全站熱搜

    lxq500c2g2 發表在 痞客邦 留言(0) 人氣()

    E-mail轉寄